Tapewire

NYSE · USD

EHC

Encompass Health Corp

Export transactions ↓
Tapewire entity
3460
SEC CIK
0000785161
Parsed reports
902

Last 12 months

Inside the activity.

0 purchase rows · 18 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202608
Mar 202601
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202606
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 07, 2017 Filed Aug 8, 2017 20:25 UTC
Tarr Mark JDirector · President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 22,625 $0.00 Strike: $16.27 $0.00
Disclosure

SEC source: 0001127602-17-025233 · form4.xml · derivative · entry 3

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Healthsouth Common Stock · 22,625 shares

Expires 2018-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 07, 2017 Filed Aug 8, 2017 20:25 UTC
Tarr Mark JDirector · President & CEO
SaleHealthsouth Common Stock 22,625 $43.00 $972,875.00
Disclosure

SEC source: 0001127602-17-025233 · form4.xml · nonDerivative · entry 2

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,509

Read SEC document
August 07, 2017 Filed Aug 8, 2017 20:25 UTC
Tarr Mark JDirector · President & CEO
Exercise / conversionHealthsouth Common Stock 22,625 $16.27 $368,108.75
Disclosure

SEC source: 0001127602-17-025233 · form4.xml · nonDerivative · entry 1

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 283,134

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 03, 2017 Filed Aug 4, 2017 13:58 UTC
Tarr Mark JDirector · President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 22,625 $0.00 Strike: $16.27 $0.00
Disclosure

SEC source: 0001127602-17-024935 · form4.xml · derivative · entry 3

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,625

Underlying: Healthsouth Common Stock · 22,625 shares

Expires 2018-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 03, 2017 Filed Aug 4, 2017 13:58 UTC
Tarr Mark JDirector · President & CEO
SaleHealthsouth Common Stock 22,625 $42.55 $962,693.75
Disclosure

SEC source: 0001127602-17-024935 · form4.xml · nonDerivative · entry 2

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,509

F1 · price: This sale price per share is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.50 to $42.66, inclusive. The reporting person undertakes to provide to HealthSouth Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Read SEC document
August 03, 2017 Filed Aug 4, 2017 13:58 UTC
Tarr Mark JDirector · President & CEO
Exercise / conversionHealthsouth Common Stock 22,625 $16.27 $368,108.75
Disclosure

SEC source: 0001127602-17-024935 · form4.xml · nonDerivative · entry 1

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 283,134

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 18, 2017 Filed Jul 19, 2017 18:55 UTC GrantHealthsouth Common Stock 74 $45.96 $3,400.97
Disclosure

SEC source: 0001127602-17-023865 · form4.xml · nonDerivative · entry 2

SHAW L EDWARD JR · CIK 0001183337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,078

F2 · shares: Pursuant to HealthSouth Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of HealthSouth common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of HealthSouth common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On July 17, 2017, the Company paid a dividend on common stock of $0.24 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of HealthSouth in the market with that dividend payment.

Read SEC document
July 18, 2017 Filed Jul 19, 2017 18:55 UTC GrantHealthsouth Common Stock 10 $45.94 $459.39
Disclosure

SEC source: 0001127602-17-023864 · form4.xml · nonDerivative · entry 2

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,950

F2 · shares: Pursuant to HealthSouth Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of HealthSouth common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of HealthSouth common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On July 17, 2017, the Company paid a dividend on common stock of $0.24 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of HealthSouth in the market with that dividend payment.

Read SEC document
July 18, 2017 Filed Jul 19, 2017 18:49 UTC
CHIDSEY JOHNDirector
GrantHealthsouth Common Stock 768 $45.88 $35,232.00
Disclosure

SEC source: 0001127602-17-023855 · form4.xml · nonDerivative · entry 2

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,594

F2 · shares: This number represents the purchase of (a) 544 shares of common stock of HealthSouth Corporation (the "Company") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the "Plan") and (b) 224 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2016 to defer fixed percentages of their directors fees for 2017. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On July 17, 2017, the Company paid a dividend on common stock of $0.24 per share.

F3 · price: This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $45.8199 to $46.009, inclusive. The reporting person undertakes to provide to HealthSouth Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.

Read SEC document
July 17, 2017 Filed Jul 19, 2017 18:55 UTC GrantHealthsouth Common Stock 322 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-023865 · form4.xml · nonDerivative · entry 1

SHAW L EDWARD JR · CIK 0001183337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,004

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
July 17, 2017 Filed Jul 19, 2017 18:55 UTC GrantHealthsouth Common Stock 322 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-023864 · form4.xml · nonDerivative · entry 1

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,940

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
July 17, 2017 Filed Jul 19, 2017 18:54 UTC GrantHealthsouth Common Stock 105 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-023862 · form4.xml · nonDerivative · entry 1

KATZ LESLYE G · CIK 0001193884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,870

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
July 17, 2017 Filed Jul 19, 2017 18:53 UTC GrantHealthsouth Common Stock 322 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-023861 · form4.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,233

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
July 17, 2017 Filed Jul 19, 2017 18:52 UTC GrantHealthsouth Common Stock 105 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-023860 · form4.xml · nonDerivative · entry 1

HERMAN JOAN E · CIK 0001248398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,870

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
July 17, 2017 Filed Jul 19, 2017 18:51 UTC GrantHealthsouth Common Stock 322 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-023859 · form4.xml · nonDerivative · entry 1

ELSON CHARLES M · CIK 0001122124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,823

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
July 17, 2017 Filed Jul 19, 2017 18:50 UTC GrantHealthsouth Common Stock 322 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-023858 · form4.xml · nonDerivative · entry 1

CURL YVONNE M · CIK 0001135567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,800

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
July 17, 2017 Filed Jul 19, 2017 18:49 UTC GrantHealthsouth Common Stock 322 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-023857 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,063

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
July 17, 2017 Filed Jul 19, 2017 18:49 UTC
CHIDSEY JOHNDirector
GrantHealthsouth Common Stock 306 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-023855 · form4.xml · nonDerivative · entry 1

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,826

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
May 04, 2017 Filed May 5, 2017 20:10 UTC GrantHealthsouth Common Stock 3,066 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-017066 · form4.xml · nonDerivative · entry 1

SHAW L EDWARD JR · CIK 0001183337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,682

F1 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

Read SEC document
May 04, 2017 Filed May 5, 2017 20:09 UTC GrantHealthsouth Common Stock 3,066 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-017064 · form4.xml · nonDerivative · entry 1

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,618

F1 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

Read SEC document
May 04, 2017 Filed May 5, 2017 20:08 UTC GrantHealthsouth Common Stock 3,066 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-017061 · form4.xml · nonDerivative · entry 1

KATZ LESLYE G · CIK 0001193884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,765

F1 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

Read SEC document
May 04, 2017 Filed May 5, 2017 20:07 UTC GrantHealthsouth Common Stock 3,066 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-017060 · form4.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,911

F1 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

Read SEC document
May 04, 2017 Filed May 5, 2017 20:06 UTC GrantHealthsouth Common Stock 3,066 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-017058 · form4.xml · nonDerivative · entry 1

HERMAN JOAN E · CIK 0001248398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,765

F1 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

Read SEC document
May 04, 2017 Filed May 5, 2017 20:05 UTC GrantHealthsouth Common Stock 3,066 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-017057 · form4.xml · nonDerivative · entry 1

ELSON CHARLES M · CIK 0001122124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,501

F1 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

Read SEC document
May 04, 2017 Filed May 5, 2017 20:05 UTC GrantHealthsouth Common Stock 3,066 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-017056 · form4.xml · nonDerivative · entry 1

CURL YVONNE M · CIK 0001135567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,478

F1 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

Read SEC document
May 04, 2017 Filed May 5, 2017 20:03 UTC
CHIDSEY JOHNDirector
GrantHealthsouth Common Stock 3,066 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-017053 · form4.xml · nonDerivative · entry 1

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,520

F1 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

Read SEC document
May 04, 2017 Filed May 5, 2017 20:04 UTC GrantHealthsouth Common Stock 3,066 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-017055 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,741

F1 · shares: Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

Read SEC document
April 19, 2017 Filed Apr 19, 2017 19:40 UTC
CHIDSEY JOHNDirector
GrantHealthsouth Common Stock 769 $44.00 $33,836.00
Disclosure

SEC source: 0001127602-17-015053 · form4.xml · nonDerivative · entry 2

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,454

F2 · shares: This number represents the purchase of (a) 540 shares of common stock of HealthSouth Corporation (the "Company") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the "Plan") and (b) 229 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2016 to defer fixed percentages of their directors fees for 2017. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On April 17, 2017, the Company paid a dividend on common stock of $0.24 per share.

Read SEC document
April 18, 2017 Filed Apr 19, 2017 19:53 UTC GrantHealthsouth Common Stock 77 $43.62 $3,358.95
Disclosure

SEC source: 0001127602-17-015061 · form4.xml · nonDerivative · entry 2

SHAW L EDWARD JR · CIK 0001183337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,616

F2 · shares: Pursuant to HealthSouth Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of HealthSouth common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of HealthSouth common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On April 17, 2017, the Company paid a dividend on common stock of $0.24 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of HealthSouth in the market with that dividend payment.

Read SEC document
April 18, 2017 Filed Apr 19, 2017 19:51 UTC GrantHealthsouth Common Stock 10 $43.63 $436.30
Disclosure

SEC source: 0001127602-17-015060 · form4.xml · nonDerivative · entry 2

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,552

F2 · shares: Pursuant to HealthSouth Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of HealthSouth common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of HealthSouth common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On April 17, 2017, the Company paid a dividend on common stock of $0.24 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of HealthSouth in the market with that dividend payment.

Read SEC document
April 17, 2017 Filed Apr 19, 2017 19:53 UTC GrantHealthsouth Common Stock 319 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-015061 · form4.xml · nonDerivative · entry 1

SHAW L EDWARD JR · CIK 0001183337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,539

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
April 17, 2017 Filed Apr 19, 2017 19:51 UTC GrantHealthsouth Common Stock 319 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-015060 · form4.xml · nonDerivative · entry 1

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,542

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
April 17, 2017 Filed Apr 19, 2017 19:50 UTC GrantHealthsouth Common Stock 92 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-015059 · form4.xml · nonDerivative · entry 1

KATZ LESLYE G · CIK 0001193884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,699

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
April 17, 2017 Filed Apr 19, 2017 19:47 UTC GrantHealthsouth Common Stock 92 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-015057 · form4.xml · nonDerivative · entry 1

HERMAN JOAN E · CIK 0001248398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,699

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
April 17, 2017 Filed Apr 19, 2017 19:49 UTC GrantHealthsouth Common Stock 319 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-015058 · form4.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,845

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
April 17, 2017 Filed Apr 19, 2017 19:46 UTC GrantHealthsouth Common Stock 319 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-015056 · form4.xml · nonDerivative · entry 1

ELSON CHARLES M · CIK 0001122124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,435

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
April 17, 2017 Filed Apr 19, 2017 19:45 UTC GrantHealthsouth Common Stock 319 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-015055 · form4.xml · nonDerivative · entry 1

CURL YVONNE M · CIK 0001135567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,412

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
April 17, 2017 Filed Apr 19, 2017 19:44 UTC GrantHealthsouth Common Stock 319 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-015054 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,675

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
April 17, 2017 Filed Apr 19, 2017 19:40 UTC
CHIDSEY JOHNDirector
GrantHealthsouth Common Stock 303 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-015053 · form4.xml · nonDerivative · entry 1

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,685

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2017, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
February 24, 2017 Filed Feb 27, 2017 23:04 UTC
Tarr Mark JDirector · President & CEO
GrantNon-qualified Stock Option (Right to Buy) · Derivative 46,754 $0.00 Strike: $42.22 $0.00
Disclosure

SEC source: 0001127602-17-008701 · form4.xml · derivative · entry 1

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,754

Underlying: Healthsouth Common Stock · 46,754 shares

Expires 2027-02-24

F1 · derivative.exercise_date: The option was exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing February 24, 2018.

Read SEC document
February 24, 2017 Filed Feb 27, 2017 23:03 UTC
COLTHARP DOUGLAS EEVP & Chief Financial Officer
GrantNon-qualified Stock Option (Right to Buy) · Derivative 24,243 $0.00 Strike: $42.22 $0.00
Disclosure

SEC source: 0001127602-17-008700 · form4.xml · derivative · entry 1

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,243

Underlying: Healthsouth Common Stock · 24,243 shares

Expires 2027-02-24

F1 · derivative.exercise_date: The option was exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing February 24, 2018.

Read SEC document
February 24, 2017 Filed Feb 27, 2017 23:02 UTC GrantNon-qualified Stock Option (Right to Buy) · Derivative 11,689 $0.00 Strike: $42.22 $0.00
Disclosure

SEC source: 0001127602-17-008699 · form4.xml · derivative · entry 1

Jacobsmeyer Barbara Ann · CIK 0001691132 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,689

Underlying: Healthsouth Common Stock · 11,689 shares

Expires 2027-02-24

F1 · derivative.exercise_date: The option was exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing February 24, 2018.

Read SEC document
February 24, 2017 Filed Feb 27, 2017 23:01 UTC
Darby John PatrickEVP, Gen Counsel & Secretary
GrantNon-qualified Stock Option (Right to Buy) · Derivative 12,338 $0.00 Strike: $42.22 $0.00
Disclosure

SEC source: 0001127602-17-008697 · form4.xml · derivative · entry 1

Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,338

Underlying: Healthsouth Common Stock · 12,338 shares

Expires 2027-02-24

F1 · derivative.exercise_date: The option was exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing February 24, 2018.

Read SEC document
February 21, 2017 Filed Feb 21, 2017 19:47 UTC Tax withholdingHealthsouth Common Stock 1,521 $42.00 $63,882.00
Disclosure

SEC source: 0001127602-17-007309 · form4.xml · nonDerivative · entry 3

Jacobsmeyer Barbara Ann · CIK 0001691132 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,099

F3 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

Read SEC document
February 21, 2017 Filed Feb 21, 2017 19:49 UTC
Tarr Mark JDirector · President & CEO
Tax withholdingHealthsouth Common Stock 1,401 $42.00 $58,842.00
Disclosure

SEC source: 0001127602-17-007315 · form4.xml · nonDerivative · entry 3

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,509

F3 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

Read SEC document
February 21, 2017 Filed Feb 21, 2017 19:48 UTC
Price Andrew LChief Accounting Officer
Tax withholdingHealthsouth Common Stock 829 $42.00 $34,818.00
Disclosure

SEC source: 0001127602-17-007313 · form4.xml · nonDerivative · entry 3

Price Andrew L · CIK 0001475399 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,646

F3 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

Read SEC document
February 21, 2017 Filed Feb 21, 2017 19:47 UTC
Levy Cheryl B.Chief Human Resources Officer
Tax withholdingHealthsouth Common Stock 1,266 $42.00 $53,172.00
Disclosure

SEC source: 0001127602-17-007311 · form4.xml · nonDerivative · entry 3

Levy Cheryl B. · CIK 0001513212 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,980

F3 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

Read SEC document
February 21, 2017 Filed Feb 21, 2017 19:46 UTC
Fay EdmundSr. Vice Pres. and Treasurer
Tax withholdingHealthsouth Common Stock 821 $42.00 $34,482.00
Disclosure

SEC source: 0001127602-17-007308 · form4.xml · nonDerivative · entry 3

Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,988

F3 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

Read SEC document
February 21, 2017 Filed Feb 21, 2017 19:45 UTC
Darby John PatrickEVP, Gen Counsel & Secretary
Tax withholdingHealthsouth Common Stock 647 $42.00 $27,174.00
Disclosure

SEC source: 0001127602-17-007307 · form4.xml · nonDerivative · entry 2

Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,487

F2 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

Read SEC document
February 21, 2017 Filed Feb 21, 2017 19:44 UTC
COLTHARP DOUGLAS EEVP & Chief Financial Officer
Tax withholdingHealthsouth Common Stock 1,271 $42.00 $53,382.00
Disclosure

SEC source: 0001127602-17-007305 · form4.xml · nonDerivative · entry 3

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,544

F3 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.